Our year-long collaboration with Maria Barna’s group and Eterna, which started at the onset of the COVID-19 pandemic, has resulted in a variety of novel methods and principles for designing stabilized mRNA therapeutics. Our first preprint describing our experimental results is up! Check out this Q&A with Maria Barna and Rhiju Das explaining why and how we did this research.
